Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Gerdes

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Allergy and Clinical Immunology|January 4, 2021
Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitisLena Möbus, Elke Rodriguez, Inken Harder, et al.
The British Journal of Dermatology|September 12, 2023
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatmentSascha Gerdes, Petra Staubach, Thomas Dirschka, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 15, 2026
S1 Guideline: Therapy of generalized pustular psoriasisRotraut Mößner, Neda Cramer, Sascha Gerdes, et al.
Dermatology and Therapy|March 23, 2020
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled TrialsCraig Leonardi, Kristian Reich, Peter Foley, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 23, 2019
Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 23, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Psoriasis (Auckland, N.Z.)|July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive StudyUlrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)|May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE StudyUlrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology|January 4, 2021
Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitisLena Möbus, Elke Rodriguez, Inken Harder, et al.
The British Journal of Dermatology|September 12, 2023
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatmentSascha Gerdes, Petra Staubach, Thomas Dirschka, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 15, 2026
S1 Guideline: Therapy of generalized pustular psoriasisRotraut Mößner, Neda Cramer, Sascha Gerdes, et al.
Dermatology and Therapy|March 23, 2020
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled TrialsCraig Leonardi, Kristian Reich, Peter Foley, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 23, 2019
Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 23, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Psoriasis (Auckland, N.Z.)|July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive StudyUlrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)|May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE StudyUlrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
Pageof 11